Lip treatments with peptides on the label are sold on two promises: that the peptide does something structural, and that the lip looks fuller. We went looking for the trials behind both. On 2026-09-08 we searched PubMed for every randomized controlled trial of a peptide applied to lips for a cosmetic outcome, and every trial of a lip plumper of any composition. Each search returned exactly one record. Between them, those two papers contain most of what is actually known, and neither says what the category implies.
The census
| Search (PubMed, 2026-09-08) | Records |
|---|---|
| Peptide + lips, cosmetic/wrinkle/aging/volume outcome, randomized controlled trials | 1 |
| Lip plumper or lip plumping, randomized controlled trials | 1 |
| Acetyl hexapeptide-8 or Argireline studied on lips or perioral area | 0 |
| Palmitoyl tripeptide-38 (Matrixyl synthe'6), any study type | 3 (none on lips) |
| Lip augmentation, randomized controlled trials | 0 |
For scale, the same database holds 139 randomized controlled trials of minoxidil in hair loss and 64 of retinoids in wrinkles or photoaging. The lip category is not under-researched relative to a difficult question; it is close to unresearched.
The one peptide lip trial, read in full
The single record is a 2025 paper covering two single-centre studies of a topical product the authors call Replenishing Lip Filler-Tiered Release Vesicles. Study 1 enrolled people who had never had lip filler or had none for twelve months. Study 2 enrolled people with prior hyaluronic acid lip augmentation three to nine months earlier and was double-blind and placebo-controlled. Participants applied the product or placebo twice daily for three weeks, followed by a two-week regression period (Moradi et al., J Cosmet Dermatol 2025).
The reported results are strong on their own terms: 94% of treated participants rated "Improved" by investigators in Study 1, 81% "Much-Improved" by themselves; 88% improved on both scales in Study 2; no adverse events.
Four details change how much that carries.
The outcomes were shine, texture and the vermilion border, plus investigator and subject global aesthetic improvement scales and satisfaction. Volume is not among them. A product named for filler was not tested for the thing filler does.
The product is not a peptide. It is a peptide-and-hyaluronic-acid combination in a proprietary tiered-release vesicle. Hyaluronic acid is a humectant with its own effect on the appearance of a dry surface, and the delivery system is itself presented as the innovation. Nothing in the outcome can be assigned to the peptide, which is the same attribution problem that runs through almost every cosmetic peptide trial.
Only one of the two studies was controlled. Study 2 was double-blind and placebo-controlled; Study 1 was not, and Study 1 is where the 94% figure comes from.
The sponsor is in the author list. Three of the six authors are employees of Ourself, the company that makes the product, and a fourth is a consultant, advisor, investigator and stockholder in it. This is disclosed in the paper, properly, and it is not an accusation — it is the normal condition of this literature, which is worth saying plainly because readers are rarely told.
Three weeks is also short. The trial's own design anticipates that, with a two-week regression period built in to see what happens when people stop.
What plumping is worth, in millimetres
The other single record is the more useful paper, because it is the only one that has put a number on the effect the whole category is selling.
Sixty female volunteers used a ginger-based lip plumper. Effects were measured at 15, 30, 60, 90 and 120 minutes, with vascularisation assessed by Mexameter and volume by anthropometric measurement and by 3D profilometry from scanning electron microscope images (Mazzarello et al., Int J Cosmet Sci 2017).
The findings, in the order that matters:
- Vascularisation rose significantly in the first 15 minutes, held unchanged to 30 minutes, then declined.
- Vermilion protrusion increased by 0.50 mm at 15 minutes.
- That increase was detected by 3D profilometry only — ordinary anthropometric measurement did not pick it up.
- The authors' own opening sentence records that no noticeable result has been shown after long-term use of these products.
Half a millimetre, for a quarter of an hour, detectable only by the more sensitive of two instruments, produced by vasodilation. That is the measured reality of lip plumping, and it is a more honest description than either the marketing or the dismissal. The mechanism is worth stating too: the effect comes from irritation and blood flow, which is why the actives in plumping products are ginger, capsaicin, menthol and cinnamon rather than peptides.
Why facial evidence does not transfer to lips
The cosmetic peptides on lip labels — the acetyl hexapeptides, the palmitoylated tripeptides — earned what evidence they have on facial skin. Our census found zero studies of Argireline or acetyl hexapeptide-8 on the lips or perioral area, and three records in total for palmitoyl tripeptide-38, none of them a lip study.
That transfer is not automatic, because lip vermilion is not skin in the ordinary sense. It carries a much thinner stratum corneum than facial skin and lacks sebaceous and sweat glands, which means its barrier, its water loss and its response to an occlusive film all differ from the cheek where the trials were run. A thinner barrier cuts both ways for a peptide: less to cross, and less protection from what crosses. Neither direction has been measured for a cosmetic peptide on a lip.
The penetration problem itself is not new here. Our page on peptides for skin sets out the molecular-weight arithmetic — copper tripeptide-1 at 402.9 daltons is the only common cosmetic peptide under the 500-dalton threshold, with acetyl hexapeptide-8 at 887.0 — and that arithmetic does not improve because the surface changed.
What a peptide lip treatment can honestly claim
It can claim to be well tolerated: no adverse events in the one trial, over three weeks. It can claim graded improvements in shine, texture and the definition of the vermilion border, from a product containing peptides among other things. It can claim that people in that trial were satisfied.
It cannot claim to add volume, because volume was not measured. It cannot attribute anything to the peptide, because the peptide was not tested alone. And it cannot borrow the plumping literature, because the one plumping study measured a vascular effect from ginger that had faded within two hours.
What would settle it
A split-lip trial of a peptide against its own vehicle, with volume measured by 3D imaging at a fixed interval, run past twelve weeks by investigators without a stake in the product. Nothing of that description exists for any peptide on any lip. Until it does, the category rests on one sponsor-affiliated three-week appearance study and one ginger paper from 2017.
More from this publication: the whole category counted in peptides for skin, the ingredients ranked by evidence in best peptides for skin, and the same treatment of the eye-area category in peptide eye creams. Our testing notes explain how we handle claims that outrun their evidence.
Sources
- PubMed searches run 2026-09-08 via NCBI E-utilities
esearch, title/abstract terms as described in the table; publication type filter"randomized controlled trial"[pt]. PubMed. - Moradi A, Jacob C, Tao J, Love R, Osborne S, Fleck T. Efficacy and Tolerability of a Topical Peptide-Hyaluronic Acid Lip Treatment Using a Novel Delivery System in Subjects With and Without Prior Lip Augmentation. J Cosmet Dermatol 2025;24(12):e70563. PubMed 41273141. Three authors are employees of Ourself, the manufacturer; one is a stockholder.
- Mazzarello V, Solinas G, Bandiera P, Pomponi V, Piu G, Ferrari M, Montella A. How long does the volumizing effect of a Zingiber officinale-based lip plumper last? Int J Cosmet Sci 2017;39(4):373-378. PubMed 27883220.
Published by Peptide Glow Journal Editorial. No product is ranked, scored or affiliate-linked on this page.